Georges Rawadi

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

Georges Rawadi served as the Chief Executive Officer and Executive Director at Celyad Oncology SA in 2023 and as the Chief Executive Officer and Director at YSOPIA Biosciences SA from 2018 to 2021.
Prior to that, he was the Vice President of Business Development at Celyad Oncology SA from 2014 to 2018 and held the same position at Cellectis SA. Rawadi holds a doctorate from Université Pierre et Marie Curie and a graduate degree from ESSEC Business School.

Precedenti posizioni note di Georges Rawadi

Società	Posizione	Fine
CELYAD ONCOLOGY SA	Amministratore Delegato	01/12/2023
YSOPIA Biosciences SA YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France.	Amministratore Delegato	01/09/2021
CELYAD ONCOLOGY SA	Corporate Officer/Principal	23/03/2018
CELLECTIS S.A.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Georges Rawadi

Formazione di Georges Rawadi

ESSEC Business School

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Georges Rawadi

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
CELYAD ONCOLOGY SA	Health Technology
CELLECTIS S.A.	Health Technology

Aziende private	2
Université Pierre et Marie Curie	Consumer Services
YSOPIA Biosciences SA YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France.	Health Technology